Thank you for your interest. White8 is now in follow-up and has closed to recruitment.
Fragility hip fractures present a significant global challenge to patients, clinicians and healthcare systems. The global literature confirms an overall mortality risk in the range 10-40% in the first year with much of this attributed to post-operative complications.
Surgical site infection (SSI) is a significant complication with literature for hemiarthroplasty infection stating rates as high as 7.3%. Therefore, the prevention of postoperative complications is likely to be one good way of reducing mortality in this group of patients.
Perioperative antibiotics are one proven means of reducing postoperative infection in patients undergoing hip arthroplasty for any indication. The current standard for cemented hip hemiarthroplasty is the use of parenteral antibiotics in combination with antibiotic loaded cement.
This will be multi centre, multi-surgeon, parallel, two arm, randomised controlled trial. This will be embedded in the World Hip Trauma Evaluation (WHITE) comprehensive cohort.
All adult patients 60 years of age and over presenting at the trial centres, who in the opinion of the treating surgeon require acute surgical treatment with a cemented hip hemiarthroplasty are eligible for inclusion.
The aim of this pragmatic randomised controlled trial is to determine the rate of deep infection in patients treated with either low dose single antibiotic loaded cement or high dose dual antibiotic loaded cement for the treatment of hip fracture with a hemi-arthroplasty.
This study is sponsored by the Northumbria Heathcare NHS Foundation Trust, and is funded by Heraeus Medical. The trial is managed by Oxford Trauma, at the University of Oxford.
05 July 2021
Our July newsletter is out; read all the news from the past month at this link.
02 July 2021
Top recruiters to the WHiTE 8 study for the past month were the Royal Cornwall Hospital and the Leicester Royal Hospital. Congratulations and a big Thank you to both!
02 July 2021
139 patients were recruited in June 2021. Thank you to all site teams for amazing work and support!
10 June 2021
The WHiTE 8 COPAL June newsletter is now out to all subscribers. You can read the news at this link.
03 June 2021
Congratulations again to the Royal Cornwall Hospital team, who were top recruiters in May 2021 as team randomised 28 new patients into WHiTE 8!
10 May 2021
The WHiTE 8 newsletter for the month of May is now out and available to read at this link.
22 April 2021
Welcome back to the University Hospital Coventry research team, who have restarted recruitment to the WHiTE 8 COPAL study today!